Full Text View
Tabular View
No Study Results Posted
Related Studies
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
This study is ongoing, but not recruiting participants.
Study NCT00674440   Information provided by University of Pennsylvania
First Received: May 5, 2008   Last Updated: January 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Hyperinsulinism
Hyperinsulinism
CHI
PHHI
Additional conditions recognized in this trial
Hypoglycemia
Nesidioblastosis
Persistent Hyperinsulinemia Hypoglycemia of Infancy
More general conditions related to this trial
Digestive System Diseases
Glucose Metabolism Disorders
Infant, Newborn, Diseases
Metabolic Diseases
Pancreatic Diseases
Interventions listed in this trial
F-DOPA
Sponsors listed in this trial
University of Pennsylvania


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services